The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial

RecruitingOBSERVATIONAL
Enrollment

458

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Multiple Myeloma
Interventions
OTHER

Peripheral blood test

We will draw 2-5 mL of peripheral blood and utilize multiparameter flow cytometry to measure the level of circulating plasma cells.

Trial Locations (1)

430022

RECRUITING

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER